ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2020

Phase 1/2 study of concurrent chemoradiotherapy with weekly irinotecan hydrochloride for advanced/recurrence uterine cancer: A multi-institutional study of Kansai Clinical Oncology Group.

Satoshi Takeuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.